EMA: Draft guideline on clinical development of fixed combination medicinal products

This guideline addresses the clinical development requirements of fixed combination medicinal products, which shall reflect their intended therapeutic use and indication. It replaces the guideline on clinical development of fixed combination medicinal products - CHMP/EWP/240/95 Rev. 1.